| 缩写名/全名 |
MABS-AUSTIN
mAbs |
||||||||||||||||||||
| ISSN号 | 1942-0862 | ||||||||||||||||||||
| 研究方向 | 工程技术-仪器仪表 | ||||||||||||||||||||
| 影响因子 | 2015:4.161, 2016:4.881, 2017:5.165, 2018:4.405, 2019:4.634, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 115 | ||||||||||||||||||||
| 出版年份 | 2009 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||
| 投稿链接 | http://mabs.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
| 投稿官网 | https://www.landesbioscience.com/journals/mabs/ | ||||||||||||||||||||
| h-index | 65 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1942-0862%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. Author: Kuo WY1, Hsu HJ1, Wu CY2, Chen HS1, Chou YC1, Tsou YL1, Peng HP1, Jian JW1,3,4, Yu CM1, Chiu YK1, Chen IC1, Tung CP1, Hsiao M1, Lin CL1, Wang YA5, Wang AH6, Yang AS1. Journal: MAbs. 2019 Jan;11(1):153-165. doi: 10.1080/19420862.2018.1541370. Epub 2018 Nov 8. PubMed DOI |
| 2. | Structure, heterogeneity and developability assessment of therapeutic antibodies. Author: Xu Y1, Wang D2, Mason B3, Rossomando T3, Li N4, Liu D5, Cheung JK6, Xu W7, Raghava S8, Katiyar A9, Nowak C3, Xiang T10, Dong DD10, Sun J11, Beck A12, Liu H3. Journal: MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17. PubMed DOI |
| 3. | De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanine. Author: Tong Y1, Fang X1, Tian H1, Zhong S1, Jin L1, Gao X1, Yao W1. Journal: MAbs. 2019 Feb/Mar;11(2):401-410. doi: 10.1080/19420862.2018.1537580. Epub 2018 Dec 22. PubMed DOI |
| 4. | Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®. Author: Xu Y1, Xie L1, Zhang E1, Gao W1, Wang L1, Cao Y1, Xie MH1, Jiang W1, Liu S1. Journal: MAbs. 2019 Apr;11(3):606-620. doi: 10.1080/19420862.2019.1578147. Epub 2019 Feb 22. PubMed DOI |
| 5. | Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy. Author: Liu H1, Guo L2,3, Zhang J1, Zhou Y1, Zhou J1, Yao J1, Wu H1, Yao S1, Chen B1, Chai Y4, Qi J4, Gao GF4, Tan S2,4, Feng H1, Yan J2,3,4. Journal: MAbs. 2019 May/Jun;11(4):681-690. doi: 10.1080/19420862.2019.1596513. Epub 2019 Apr 19. PubMed DOI |
| 6. | Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody. Author: Zhao J1, Jiang L1, Deng L1, Xu W1, Cao Y1, Chen C1, Yang Y1, Wu H1, Huang Y1, Zhu Z1, Huang H1. Journal: MAbs. 2019 Apr 5:1-11. doi: 10.1080/19420862.2019.1601985. [Epub ahead of print] PubMed DOI |
| 7. | Multi-Site N-glycan mapping study 1: Capillary electrophoresis - laser induced fluorescence. Author: Szekrényes Á, Park SS, Santos M, Lew C, Jones A, Haxo T, Kimzey M, Pourkaveh S, Szabó Z, Sosic Z, Feng P, Váradi C, de l'Escaille F, Falmagne JB, Sejwal P, Niedringhaus T, Michels D, Freckleton G, Hamm M, Manuilov A, Schwartz M, Luo JK, van Dyck J, Leung PK, Olajos M, Gu Y, Gao K, Wang W, Wegstein J, Tep S, Guttman A. Journal: MAbs. 2016;8(1):56-64. doi: 10.1080/19420862.2015.1107687. Epub 2015 Oct 14. PubMed |
| 8. | A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect. Author: Wang W, Sun L, Li T, Ma Y, Li J, Liu Y, Li M, Wang L, Li C, Xie Y, Wen Y, Liang M, Chen L, Tong S. Journal: MAbs. 2016 Apr;8(3):468-77. doi: 10.1080/19420862.2015.1134409. Epub 2015 Dec 29. PubMed |
| 9. | Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy. Author: Yang Y, Guo Q, Chen X, Zhang J, Guo H, Qian W, Hou S, Dai J, Li B, Guo Y, Wang H. Journal: MAbs. 2016;8(2):405-13. doi: 10.1080/19420862.2015.1127491. PubMed |
| 10. | A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion. Author: Shi X, Deng Y, Wang H, Ji G, Tan W, Jiang T, Li X, Zhao H, Xia T, Meng Y, Wang C, Yu X, Yang Y, Li B, Qin ED, Dai J, Qin CF, Guo Y. Journal: MAbs. 2016 Apr;8(3):574-84. doi: 10.1080/19420862.2016.1148850. Epub 2016 Feb 23. PubMed |
|
|
